Ceretype

Curated by Signal

AI-based brain biomarker technology to improve drug discovery and patient care

Overview

AI-based brain biomarker technology to improve drug discovery and patient care. The company offers an AI-based fMRI p brain imaging technology to revolutionize neuropsychiatric healthcare by providing actionable visibility into brain circuitry to improve drug discovery and patient care.

Key facts

Founded: 2020
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

CompStar Systems
Medical bill review and case managment software
Health TechnologyTustin, United States
Elait Health
Provider of a cloud-based health data management platform for healthcare organisations
Health TechnologyLewes, United States
Focalyx
Provider of an app and solutions to providers and patients
Health TechnologySheridan, United States

About Ceretype

What does Ceretype do?

AI-based brain biomarker technology to improve drug discovery and patient care.

Where is Ceretype headquartered?

Ceretype is headquartered in Cambridge, United States.

When was Ceretype founded?

Ceretype was founded in 2020.

Which sector is Ceretype in?

Ceretype operates in Health Technology.

Who are Ceretype's competitors?

Companies similar to Ceretype include CompStar Systems, Elait Health, and Focalyx.